| CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses KE Lineburg, EJ Grant, S Swaminathan, DSM Chatzileontiadou, C Szeto, ... Immunity 54 (5), 1055-1065. e5, 2021 | 151 | 2021 |
| The Many Faces of CD4+ T Cells: Immunological and Structural Characteristics DSM Chatzileontiadou, H Sloane, AT Nguyen, S Gras, EJ Grant International journal of molecular sciences 22 (1), 73, 2020 | 79 | 2020 |
| A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection DG Augusto, LD Murdolo, DSM Chatzileontiadou, JJ Sabatino Jr, ... Nature 620 (7972), 128-136, 2023 | 73 | 2023 |
| Natural flavonoids as antidiabetic agents. The binding of gallic and ellagic acids to glycogen phosphorylase b E Kyriakis, GA Stravodimos, AL Kantsadi, DSM Chatzileontiadou, ... FEBS letters 589 (15), 1787-1794, 2015 | 63 | 2015 |
| Biochemical and biological assessment of the inhibitory potency of extracts from vinification byproducts of Vitis vinifera extracts against glycogen phosphorylase AL Kantsadi, A Apostolou, S Theofanous, GA Stravodimos, E Kyriakis, ... Food and chemical toxicology 67, 35-43, 2014 | 58 | 2014 |
| Synthetic, enzyme kinetic, and protein crystallographic studies of C-â-d-glucopyranosyl pyrroles and imidazoles reveal and explain low nanomolar inhibition of human liver … AL Kantsadi, É Bokor, S Kun, GA Stravodimos, DSM Chatzileontiadou, ... European Journal of Medicinal Chemistry 123, 737-745, 2016 | 52 | 2016 |
| Phytogenic polyphenols as glycogen phosphorylase inhibitors: the potential of triterpenes and flavonoids for glycaemic control in type 2 diabetes G A Stravodimos, B A Chetter, E Kyriakis, A L Kantsadi, ... Current medicinal chemistry 24 (4), 384-403, 2017 | 48 | 2017 |
| The unconventional role of HLA-E: The road less traveled EJ Grant, AT Nguyen, CA Lobos, C Szeto, DSM Chatzileontiadou, S Gras Molecular immunology 120, 101-112, 2020 | 43 | 2020 |
| Triazole pyrimidine nucleosides as inhibitors of Ribonuclease A. Synthesis, biochemical, and structural evaluation V Parmenopoulou, DSM Chatzileontiadou, S Manta, S Bougiatioti, ... Bioorganic & medicinal chemistry 20 (24), 7184-7193, 2012 | 43 | 2012 |
| Structure based inhibitor design targeting glycogen phosphorylase b. Virtual screening, synthesis, biochemical and biological assessment of novel N-acyl-â-d-glucopyranosylamines V Parmenopoulou, AL Kantsadi, VG Tsirkone, DSM Chatzileontiadou, ... Bioorganic & medicinal chemistry 22 (17), 4810-4825, 2014 | 31 | 2014 |
| Probing the â-pocket of the active site of human liver glycogen phosphorylase with 3-(C-â-d-glucopyranosyl)-5-(4-substituted-phenyl)-1, 2, 4-triazole inhibitors E Kyriakis, TGA Solovou, S Kun, K Czifrák, B Szőcs, L Juhász, É Bokor, ... Bioorganic chemistry 77, 485-493, 2018 | 27 | 2018 |
| The presentation of SARS-CoV-2 peptides by the common HLA-A∗ 02: 01 molecule C Szeto, DSM Chatzileontiadou, AT Nguyen, H Sloane, CA Lobos, ... Iscience 24 (2), 2021 | 20 | 2021 |
| van der Waals interactions govern C-â-D-glucopyranosyl triazoles¢ nM inhibitory potency in human liver glycogen phosphorylase AL Kantsadi, GA Stravodimos, E Kyriakis, DSM Chatzileontiadou, ... Journal of Structural Biology 199 (1), 57-67, 2017 | 20 | 2017 |
| Triazole double-headed ribonucleosides as inhibitors of eosinophil derived neurotoxin DSM Chatzileontiadou, V Parmenopoulou, S Manta, AL Kantsadi, ... Bioorganic Chemistry 63, 152-165, 2015 | 19 | 2015 |
| Protein purification and crystallization of HLA-A∗ 02: 01 in complex with SARS-CoV-2 peptides DSM Chatzileontiadou, C Szeto, D Jayasinghe, S Gras STAR protocols 2 (3), 100635, 2021 | 18 | 2021 |
| Molecular basis of a dominant SARS-CoV-2 spike-derived epitope presented by HLA-A* 02: 01 recognised by a public TCR C Szeto, AT Nguyen, CA Lobos, DSM Chatzileontiadou, D Jayasinghe, ... Cells 10 (10), 2646, 2021 | 17 | 2021 |
| The ammonium sulfate inhibition of human angiogenin DSM Chatzileontiadou, VG Tsirkone, K Dossi, AG Kassouni, PGV Liggri, ... FEBS letters 590 (17), 3005-3018, 2016 | 16 | 2016 |
| Evidence for Novel Action at the Cell‐Binding Site of Human Angiogenin Revealed by Heteronuclear NMR Spectroscopy, in silico and in vivo Studies DSM Chatzileontiadou, AC Tsika, Z Diamantopoulou, J Delbé, J Badet, ... ChemMedChem 13 (3), 259-269, 2018 | 13 | 2018 |
| Impact of HLA-DR antigen binding cleft rigidity on T cell recognition C Szeto, JI Bloom, H Sloane, CA Lobos, J Fodor, D Jayasinghe, ... International journal of molecular sciences 21 (19), 7081, 2020 | 10 | 2020 |
| Proteomic analysis of human angiogenin interactions reveals cytoplasmic PCNA as a putative binding partner DSM Chatzileontiadou, M Samiotaki, AN Alexopoulou, M Cotsiki, ... Journal of Proteome Research 16 (10), 3606-3622, 2017 | 9 | 2017 |
